Evidence map›Paper›PMID 37333382›Full record

ArticlemedRxiv : the preprint server for health sciences2023

Quantitative CT of Normal Lung Parenchyma and Small Airways Disease Topologies are Associated With COPD Severity and Progression.

Alexander J Bell, Ravi Pal, Wassim W Labaki, Benjamin A Hoff, Jennifer M Wang, Susan Murray, Ella A Kazerooni, Stefanie Galban, David A Lynch, Stephen M Humphries and 5 more

Open access · greenAbstract readPreprint
In one paragraph

Article in medRxiv : the preprint server for health sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 1 country.

Alexander J BellDepartment of Radiology, University of Michigan, Ann Arbor, MI, United States.
Ravi PalDepartment of Radiology, University of Michigan, Ann Arbor, MI, United States.
Wassim W LabakiDepartment of Internal Medicine, Division of Pulmonary and Critical Care Medicine, University of Michigan, Ann Arbor, MI, United States.
Benjamin A HoffDepartment of Radiology, University of Michigan, Ann Arbor, MI, United States.
Jennifer M WangDepartment of Internal Medicine, Division of Pulmonary and Critical Care Medicine, University of Michigan, Ann Arbor, MI, United States.
Susan MurraySchool of Public Health, University of Michigan, Ann Arbor, MI, United States.
Ella A KazerooniDepartment of Radiology, University of Michigan, Ann Arbor, MI, United States.
Stefanie GalbanDepartment of Radiology, University of Michigan, Ann Arbor, MI, United States.
David A LynchDepartment of Radiology, National Jewish Health, Denver, CO, United States.
Stephen M HumphriesDepartment of Radiology, National Jewish Health, Denver, CO, United States.
Fernando J MartinezWeill Cornell Medical College, New York, NY, United States.
Charles R HattImbio, LLC, Minneapolis, MN, United States.
MeiLan K HanDepartment of Internal Medicine, Division of Pulmonary and Critical Care Medicine, University of Michigan, Ann Arbor, MI, United States.
Sundaresh RamDepartment of Radiology, University of Michigan, Ann Arbor, MI, United States.ORCID 0000-0003-1828-9722
Craig J GalbanDepartment of Radiology, University of Michigan, Ann Arbor, MI, United States.
University of Michigan · USNational Jewish Health · USCornell University · USImbio (United States) · US

Funding

Genetic Epidemiology of COPDU01HL089897 · NHLBI · NATIONAL JEWISH HEALTH · PI CRAPO, JAMES D · 2007 to 2021
$56.9M
Genetic Epidemiology of COPDU01HL089856 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI SILVERMAN, EDWIN K · 2007 to 2021
$20.7M
PULMONARY CELLULAR AND MOLECULAR BIOLOGY TRAININGT32HL007749 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Robert Pickett Dickson · 1993 to 2026
$19.9M
Prediction of COPD Progression by PRMR01HL150023 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI GALBAN, CRAIG J, HAN, MEILAN K · 2020 to 2023
$2.8M
An Early Imaging Marker of EmphysemaR01HL139690 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI GALBAN, CRAIG J · 2019 to 2022
$1.9M
Preclinical Services for Biopharmaceutical Product Development75N93023D00011 · NIAID · ALLUCENT GOVERNMENT SERVICES (US) LLC · 2023 to 2023
$7k
BIOLOGY OF PNEUMOCYSTIS IN VITRO AND IN VIVOZ01CL000011 · CLC · CLINICAL CENTER · PI MASUR, H · 1985 to 1987
–
CLC NIH HHS 75N90023D00011NHLBI NIH HHS 75N92021D00011NHLBI NIH HHS R01 HL139690NHLBI NIH HHS R01 HL150023NHLBI NIH HHS T32 HL007749NHLBI NIH HHS U01 HL089856NHLBI NIH HHS U01 HL089897NIAID NIH HHS 75N93023D00011
6 · The paper itself

Abstract

Objectives: Small airways disease (SAD) is a major cause of airflow obstruction in COPD patients, and has been identified as a precursor to emphysema. Although the amount of SAD in the lungs can be quantified using our Parametric Response Mapping (PRM) approach, the full breadth of this readout as a measure of emphysema and COPD progression has yet to be explored. We evaluated topological features of PRM-derived normal parenchyma and SAD as surrogates of emphysema and predictors of spirometric decline. Materials and Methods: PRM metrics of normal lung (PRM Results: Multivariable cross-sectional analysis of COPD subjects showed that V and χ measures for PRM Conclusions: We demonstrated that V and χ of fSAD and Norm have independent value when associated with lung function and emphysema. In addition, we demonstrated that these readouts are predictive of spirometric decline when used as inputs in a ML model. Our topological PRM approach using PRM

Indexed as

chronic obstructive pulmonary diseasecomputed tomography of the chestemphysemamachine learningparametric response mappingsmall airways disease

Identifiers

PMID37333382
PMCPMC10274970
OpenAlexW4379375489

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.